Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers

Human Pathology

Volumn 42, Issue 5, 2011, Pages 688-701

  Murnane, Mary Jo ^a   Cai, Jinguo ^a   Shuja, Sania ^b   McAneny, David ^a   Willett, John B ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c HARVARD GRADUATE SCHOOL OF EDUCATION   (United States)

Author keywords

Active MMP 2; Colorectal adenomas; High grade dysplasia; Tumor progression

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SIZE; CARCINOGENESIS; CHILD; COLON ADENOMA; COLON MUCOSA; COLORECTAL CARCINOMA; DISEASE CLASSIFICATION; DYSPLASIA; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; ZYMOGRAPHY;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ENZYME ACTIVATION; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; YOUNG ADULT;

EID: 79954594992     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.08.021     Document Type: Article

References (49)

1. Rex D.K., and Goldblum J.R. PRO: villous elements and high grade dysplasia help guide post-polypectomy colonoscopic surveillance Am J Gastroenterol 103 2008 1327 1329
2. Appelman H.D. CON: high-grade dysplasia and villous features should not be part of the routine diagnosis of colorectal adenomas Am. J. Gastroenterol 103 2008 1329 1331 (Pubitemid 351813944)
3. Odze R. A balancing view: pathologist-clinician interaction is essential Am. J. Gastroenterol 103 2008 1331 1333 (Pubitemid 351813945)
4. Murnane M.J., Cai J., Shuja S., McAneny D., Klepeis V., and Willett J.A. Active MMP-2 effectively identified the presence of colorectal cancer Int. J. Cancer 125 2009 2893 2902
5. Heslin M.J., Yan J., Johnson M.R., Weiss H., Diasio R.B., and Urist M.M. Role of matrix metalloproteinases in colorectal carcinogenesis Annals Surg 233 2001 786 792 (Pubitemid 32494559)
6. Kumar V., Abbas A., and Fausto N. 7th ed Robbins and Cotran pathologic basis of disease 2005 Elsevier Saunders Philadelphia (PA) 862
7. American Joint Committee on Cancer 3rd ed Manual for staging cancer 1988 J.B. Lippincott Philadelphia (PA)
8. Rosner B. Fundamentals of biostatistics 2000 Duxbury Pacific Grove (CA)
9. Nichols E.A., and Ruddle F.H.A. Review of enzyme polymorphism, linkage and electrophoretic conditions for mouse and somatic cell hybrids in starch gel J. Histochem 21 1973 1066 1081
10. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent J Biol Chem 193 1951 265 275
11. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L., and Sawaya R. Elevated levels of Mr 92,000 type IV collagenase in human brain tumors Canc Res 53 1993 2208 2211 (Pubitemid 23156800)
12. Murnane MJ, Shuja S, Del Re E, Cai J, Iacobuzio-Donahue C, Klepeis V. Characterizing human colorectal carcinomas by proteolytic profile. In vivo 1997;11:209-216
13. Itoh Y., Binner S., and Nagase H. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate Biochem J 308 1995 645 651
14. Birkedal-Hansen H., and Taylor R.E. Detergent-activation of latent collagenase and resolution of its component molecules Biochem Biophys Res Comm 107 1982 1173 1178
15. Murnane M.J., Cai J., and Shuja S. Changing patterns of proteolytic expression with colorectal tumor progression M. Suzuki, T Hiwasa, Proteases involved in cancer 1994 Monduzzi Editore Bologna, Italy 1 11
16. Xia T., Akers K., Eisen A.Z., and Seltzer J.L. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides Biochim Biophys Acta 1293 1996 259 266 (Pubitemid 26122218)
17. Kolkenbrock H., Hecker-Kia A., Orgel D., Kinawi A., and Ulbrich N. Progelatinase B forms from human neutrophils. Complex formation of monomer/lipocalin with TIMP-1. Biol Chem 377 1996 529 533 (Pubitemid 26383904)
18. Hosmer D.W., and Lemeshow S. Applied logistic regression 2nd ed 2000 John Wiley & Sons New York (NY)
19. Winawer S.J., Zauber A.G., and Fletcher R.H. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society Gastroenterology 130 2006 1872 1885 (Pubitemid 43668826)
20. Riddell RH, Petras RE, Williams GT and Sobin LH. Epithelial neoplasms of the intestines. In: Atlas of tumor pathology, tumors of the intestines, American Registry of PathologyWashington, DC: American registry of pathology; 2002. Washington, DC, Chapter 3, pp. 85-100.
21. Newell K.J., Witty J.P., Rodgers W.H., and Matrisian L.M. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis Mol Carcinog 10 1994 199 206 (Pubitemid 24283035)
22. Kirimlioglu H., Kirimlioglu V., and Yilmaz S. Role of matrix metalloproteinase-7 in colorectal adenomas Dig Dis Sci 51 2006 2068 2072 (Pubitemid 44832593)
23. Herszenyi L., Sipos F., and Galamb O. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon Pathol Oncol Res 14 2008 31 37
24. Daniel P., Wagrowska-Danilewicz M., Danilewicz M., Stasikowska O., and Malecka-Panas E. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma Int J Colorectal Dis 22 2007 1165 1172 (Pubitemid 47304784)
25. Gimeno-Garcia A.Z., Santana-Rodriguez A., and Jimenez A. Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence European J Cancer 42 2006 3146 3252
26. Parsons S.L., Watson S.A., Collins H.M., Griffin N.R., Clarke P.A., and Steele R.J. Gelatinase (MMP-2 and 9) expression in gastrointestinal malignancy Br J Cancer 78 1998 1495 1502 (Pubitemid 28517547)
27. Baker E.A., Bergin F.G., and Leaper D.J. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging Br J Surg 87 2000 1215 1221
28. Kleiner D.E., and Stetler-Stevenson W.G. Quantitative zymography: detection of picogram quantities of gelatinases Anal Biochem 218 1994 325 329 (Pubitemid 24141631)
29. Fodde R, Smits R, and Clevers H APC, signal transduction and genetic instability in colorectal cancer Nat Rev Cancer 2001 55 67 (Pubitemid 33741881)
30. Hermsen M., Postma C., and Baak J. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability Gastroenterol 123 2001 1109 1119
31. Takeuchi N., Ichikawa Y., and Ishikawa T. Matrilysin gene expression in sporadic and familial colorectal adenomas Mol Carcinog 24 1997 177 187
32. Caterina J.J., Yamada S., and Caterina N.C. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2 (TIMP-2) gene alters proMMP-2 activation J Biol Chem 275 2000 26416 26422
33. Hernandez-Barrantes S., Toth M., and Bernardo M.M. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation J Biol Chem 275 2000 12080 12089 (Pubitemid 30237783)
34. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase J Biol Chem 270 1995 5331 5338
35. Wang Z., Juttermann R., and Soloway P.D. TIMP-2 is required for efficient activation of proMMP-2 in vivo J Biol Chem 275 2000 26411 26415
36. Zucker S., and Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer Cancer and Metastasis Rev 23 2004 101 117 (Pubitemid 38221598)
37. Sardinha T.C., Nogueras J.J., Xiong H., Weiss E.G., Wexner S.D., and Abramson S. Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer Dis Colon Rectum 43 2000 389 395 (Pubitemid 30158577)
38. Malhotra S., Newman E., and Eisenberg D. Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: a possible mechanism of neoplastic progression Dis Colon Rectum 45 2002 537 543 (Pubitemid 34407733)
39. Ornstein D.L., and Cohn K.H. The balance between activation and inhibition of matrix metalloproteinase-2 is altered in colorectal tumors compared to normal colonic epithelium Dig Dis Sci 47 2002 1821 1830 (Pubitemid 34833215)
40. Kikuchi R., Noguchi T., Takeno S., Kubo N., and Uchida Y. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma Br J Cancer 83 2000 215 218 (Pubitemid 30411720)
41. Ra H.J., and Parks W.C. Control of matrix metalloproteinase catalytic activity Matrix Biol 26 2007 587 596 (Pubitemid 350180394)
42. Morrison C.J., Butler G.S., Bigg H.F., Roberts C.R., Soloway P.D., and Overall C.M. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway J Biol Chem 276 2001 47402 47410
43. Zhao H., Bernardo M.M., and Osenkowski P. Differential Inhibition of MT3-MMP and MT1-MMP by TIMP-2 and TIMP-3 regulates pro-MMP-2 activation J Biol Chem 279 2004 8592 8601
44. English J.L., Kassiri Z., and Koskivirta I. Individual Timp deficiencies differentially impact pro-MMP-2 activation J Biol Chem 281 2006 10337 10346 (Pubitemid 43864572)
45. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., and Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2 J Biol Chem 280 2005 9291 9296 (Pubitemid 40409621)
46. Okamoto T., Akaike T., and Nagano T. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide Arch Biochem Biophys 342 1997 261 274 (Pubitemid 27251247)
47. Kim K.H., Cho Y.S., Park J.M., Yoon S.O., Kim K.W., and Chung A.S. Pro-MMP-2 activation by the PPARγ agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK FEBS Lett 581 2007 3303 3310 (Pubitemid 46977368)
48. Ogino S., and Goel A. Molecular classification and correlates in colorectal cancer J Mol Diagn 10 2008 13 27 (Pubitemid 351184831)
49. Soreide K., Nedrebo B.S., Knapp J.C., Glomsaker T.B., Soreide J.A., and Korner H. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist Surg Oncol 18 2009 31 50